3
2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11466 | GSK-2793660 | Others | |
GSK-2793660 is an orally active and irreversible inhibitor of Cathepsin C (CTSC). GSK-2793660 is a bioactive dipeptide that can be used for the research of bronchiectasis [1] [2]. | |||
T27468 | GSK2793660 HCl | GSK-2793660,GSK2793660,GSK 2793660 | |
GSK2793660 is a irreversible covalent α,β-unsaturated amide based DPP1 inhibitor. | |||
T70381 | GSK2793660 free base | ||
GSK-2793660 is a cathepsin C inhibitor that may be useful in the treatment of cystic fibrosis, noncystic fibrosis bronchiectasis, ANCA-associated vasculitis and bronchiectasis. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02628 | Cathepsin C Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli |
Thiol protease. Has dipeptidylpeptidase activity. Can act as both an exopeptidase and endopeptidase. Can degrade glucagon. Plays a role in the generation of cytotoxic lymphocyte effector function. | |||
TMPY-00732 | Cathepsin C Protein, Human, Recombinant (His) | Human | HEK293 Cells |
Cathepsins are proteases found in many types of cells conserved in all animals, which have a vital role in mammalian cellular turnover such as bone resorption. The lysosomal cysteine protease Cathepsin C (CTSC), also kno... |